FDA approves first drug for common form of liver inflammation

The US Food and Drug Administration has approved the first medication for a common form of liver inflammation called nonalcoholic steatohepatitis, or NASH, the agency said Thursday. NASH — also known as metabolic dysfunction-associated steatohepatitis, or MASH — happens when the liver becomes…#nash #fda #rezdiffra #breakthroughtherapy #wayneeskridge #fattyliverfoundation #madrigal #pierregholam #universityhospitals #cleveland
Source: Reuters: Health - Category: Consumer Health News Source Type: news